LGALS3 and in situ carcinoma: Our findings regarding the significantly higher concentrations of kidney-phosphorylated AMP-activated protein kinase (p-AMPK) in CIS-treated Gal-3 KO mice compared to CIS-treated Gal-3 wild-type mice are noteworthy.